Algernon Neuroscience Inc. — Regulation A 1-A/A
Algernon Neuroscience Inc. of Vancouver, A1 filed a Regulation A 1-A/A with the SEC on 2023-01-19. Aggregate offering: $10.0M (Tier 2). Industry: Other.
Offering
- Filed: 2023-01-19
- Form: 1-A/A
- Accession: 0001062993-23-001043
- Tier: Tier 2
- Total aggregate offering: $10.0M
- Issuer portion: $10.0M
- Price per security: $1.0000
- Securities offered: Equity (common or preferred stock)
- Broker-dealer CRD: 136352
- Audit status: Audited
- Auditor: Smythe LLP
- Jurisdictions: 128 states/territories
Issuer
- CIK: 0001959708
- Organized in: A1
- Incorporated: 2022
- Address: 400-601 West Broadway, Vancouver, A1, V5Z 4C2
- Phone: 604-398-4175
Financial snapshot (as filed)
- Total assets: $35K
- Total liabilities: $1.9M
- Stockholder equity: $-1.9M
- Net income: $-1.2M
People (2)
| Name | Role | Location |
|---|
| James Kinley | Chief Financial Offficer | Vancouver, A1 |
| James Kinley | Signer | Vancouver, A1 |
Other Reg A filings by this issuer (6)
More